Skip to main content
Addgene

AAV2/9 REP-AAP-ΔCAP
(Plasmid #205991)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 205991 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    recombinant AAV2/9
  • Vector type
    AAV

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    30°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    AAV9 Rep and AAP proteins for CREATE libraries
  • Species
    Synthetic

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

This work was supported by funding from:
NIH BRAIN Armamentarium UF1MH128336
Michael J Fox Foundation for Parkinson's Research ASAP-020495
Additional information may be found in Ravindra Kumar, Sripriya et al. “Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types.” Nature methods vol. 17,5 (2020): 541-550. doi:10.1038/s41592-020-0799-7

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    AAV2/9 REP-AAP-ΔCAP was a gift from Viviana Gradinaru (Addgene plasmid # 205991 ; http://n2t.net/addgene:205991 ; RRID:Addgene_205991)
  • For your References section:

    Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain. Chuapoco MR, Flytzanis NC, Goeden N, Christopher Octeau J, Roxas KM, Chan KY, Scherrer J, Winchester J, Blackburn RJ, Campos LJ, Man KNM, Sun J, Chen X, Lefevre A, Singh VP, Arokiaraj CM, Shay TF, Vendemiatti J, Jang MJ, Mich JK, Bishaw Y, Gore BB, Omstead V, Taskin N, Weed N, Levi BP, Ting JT, Miller CT, Deverman BE, Pickel J, Tian L, Fox AS, Gradinaru V. Nat Nanotechnol. 2023 Jul 10. doi: 10.1038/s41565-023-01419-x. 10.1038/s41565-023-01419-x PubMed 37430038